Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
ICP DAS-BMP Brings Advanced Medical TPU Portfolio to Medical Manufacturing Asia 2026
7+ hour, 52+ min ago (184+ words) The spotlight will be on two TPU innovations addressing critical needs in medical device manufacturing: the Low-Migration Series and the Low-Friction Series. The Low-Migration Arothane™ ARP-B20 TPU complies with ISO 10993 and is suitable for implantation up to 90 days. Its unique…...
Center of Geriatric Nursing Excellence announces fall 2026 seminar series | Penn State University
8+ hour, 25+ min ago (273+ words) Tressa Nese and Helen Diskevich Center of Geriatric Nursing Excellence (CGNE) Seminar Series. Credit: Penn State. Creative Commons UNIVERSITY PARK, Pa. — The Ross and Carol Nese College of Nursing’s Tressa Nese and Helen Diskevich Center of Geriatric Nursing Excellence (CGNE)…...
Valley Medical Cancer Center begins new construction phase
2+ hour, 49+ min ago (374+ words) Published 1:05 pm Tuesday, August 25, 2026 Guests were greeted by therapy dogs at the Cancer Center ribbon cutting. Valley Medical Center & Clinics in Renton has been working on completing its Cancer Center, which has been under construction in stages since 2024. On Aug....
AHN to collaborate with cancer research group
58+ min ago (282+ words) Butler Eagle - News Local News News By Location Government Education Crime & Courts Police Reports Butler County's Most Wanted Health Business News Agriculture Real Estate Transfers Tax Sales Jobless Figures Business Matters Beyond Butler County Pennsylvania News National News International News…...
Urgent call for ACT residents to help shape the future of gynaecological cancer care
1+ hour, 47+ min ago (648+ words) Wednesday, 26 August 2026 Every day in Australia, 19 people are diagnosed with a gynaecological cancer, including ovarian, uterine/endometrial, cervical, vulvar and vaginal cancers, and tragically, six people lose their lives. Behind every diagnosis is a deeply personal experience of navigating symptoms,…...
The Inner Circle acknowledges Susan K. Sparkman, MD as a 2026 Legacy Achiever
1+ hour, 49+ min ago (335+ words) PR Newswire BELLAIRE, Texas, Aug. 25, 2026 /PRNewswire/ -- Prominently featured in The Inner Circle, Susan K. Sparkman, MD is acknowledged as a 2026 Legacy Achiever for her contributions to Psychiatry and Integrative Mental Health. Dr. Susan K. Sparkman has established a remarkable legacy in psychiatry,…...
FDA grants orphan drug designation to BAL0891 for AML
3+ hour, 52+ min ago (365+ words) All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional. If you are a patient or carer, please visit…...
How a professor is working to make sure residents aren’t exposed to diseases transmitted by ticks
57+ min ago (147+ words) WSOC TV Inside look at law enforcement & true crime Your one-stop shop for delicious dishes Big 22: Indian Landâs Matt Kucia How a professor is working to make sure residents arenât exposed to diseases transmitted by ticks Man charged…...
Fundraiser organized to help fight return of rare bone cancer - Salt Spring Island news
1+ hour, 56+ min ago (389+ words) A Salt Spring-raised man who beat a rare form of bone cancer when he was a teenager is once again facing a battle for his life. At age 14, Darcy Ross MacLean was diagnosed with adamantinoma, requiring major surgeries to replace…...
U.S. FDA Approves Ziihera?? (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma
4+ hour, 34+ min ago (200+ words) The approval is supported by results from the Phase 3 HERIZON-GEA-01 trial, which demonstrated the benefit of zanidatamab in combination with immunotherapy and chemotherapy in the first-line treatment of HER2+ GEA. Results from the study were published in the New England Journal…...